Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma.

Medicine (Baltimore) · 2019 · PMC6708874 · PMID 31393377

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, stage I and III patients who expressed low CD133 levels showed a trend of better OS rates, although the differences were not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.